Related Experiment Videos
[Cardiac anomalies in chronic renal failure]
A Guérin1, S Marchais, B Pannier
1Service de Néphrologie et d'Hémodialyse, Centre hospitalier F.H. Manhes, Fleury Mérogis.
Presse Medicale (Paris, France : 1983)
|March 4, 2000
Summary
Cardiovascular complications are the primary cause of death in end-stage renal disease (ESRD). Management focuses on treating underlying causes like anemia and fluid overload, rather than specific cardiac treatments.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Cardiovascular diseases (CVD) are the leading cause of mortality in end-stage renal disease (ESRD) patients.
- Common complications include left ventricular hypertrophy, arterial degenerative lesions, pericarditis, and calcifying valvulopathy.
Purpose of the Study:
- To summarize the principal cardiovascular complications in end-stage renal disease.
- To explore the complex multifactorial etiology of these complications.
- To outline current treatment strategies.
Main Methods:
- Literature review and synthesis of existing data on cardiovascular complications in ESRD.
- Analysis of risk factors, including uremia-specific and general population factors.
- Discussion of treatment approaches targeting underlying causes.
Main Results:
- ESRD patients exhibit high rates of left ventricular hypertrophy and coronary artery disease.
- Uremia-related factors (anemia, overhydration, dialysis access) and hemodynamic alterations contribute significantly.
- Effective management involves addressing anemia, fluid balance, and blood pressure control.
Conclusions:
- Cardiovascular complications are a major concern in ESRD, driven by complex factors.
- Treatment strategies should prioritize managing uremia and associated conditions.
- Further research is needed to fully elucidate the role of various substances in disease pathogenesis.